Cargando…

Late Dental Toxicities After Proton Chemoradiation for Rhabdomyosarcoma: A Pediatric Case Report

PURPOSE: Radiation therapy is an independent risk factor for adverse sequelae to the oral cavity and dentition in childhood cancer survivors. However, dental toxicities after radiation therapy often are underreported and there are minimal published data on disturbances in tooth development after pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Foster-Thomas, Emma, Aznar, Marianne, Indelicato, Daniel, Pan, Shermaine, Hwang, Eunji, Sitch, Peter, Horner, Keith, Smith, Ed, Gaito, Simona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Particle Therapy Co-operative Group 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875822/ https://www.ncbi.nlm.nih.gov/pubmed/36721482 http://dx.doi.org/10.14338/IJPT-22-00011.1

Ejemplares similares

Proton Beam Therapy in the Oligometastatic/Oligorecurrent Setting: Is There a Role? A Literature Review
por: Gaito, Simona, et al.
Publicado: (2023)

Predictors of Acute and Late Toxicity in Patients Receiving Chemoradiation for Unresectable Pancreatic Cancer
por: Das, Rishi, et al.
Publicado: (2023)

Potential of Proton Therapy to Reduce Acute Hematologic Toxicity in Concurrent Chemoradiation Therapy for Esophageal Cancer
por: Warren, Samantha, et al.
Publicado: (2017)

Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma
por: Vennarini, Sabina, et al.
Publicado: (2023)

Pencil Beam Scanning Proton Therapy for Rhabdomyosarcoma of the Biliary Tract
por: Pater, Luke, et al.
Publicado: (2017)

Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer
por: Shi, Feiya, et al.
Publicado: (2022)

Late toxicities among laryngopharyngeal cancers patients treated with different schedules of concurrent chemoradiation at a rural tertiary cancer care center
por: Muttath, Geetha, et al.
Publicado: (2019)

Proton beam therapy for a patient with large rhabdomyosarcoma of the body trunk
por: Takizawa, Daichi, et al.
Publicado: (2015)

Late radiation toxicity in Hodgkin lymphoma patients: proton therapy's potential
por: Toltz, Allison, et al.
Publicado: (2015)

Efficacy and toxicity of chemoradiation in patients with anal cancer - a retrospective analysis
por: Koerber, Stefan Alexander, et al.
Publicado: (2014)

Acute toxicity of definitive chemoradiation in patients with inoperable or irresectable esophageal carcinoma
por: Haj Mohammad, Nadia, et al.
Publicado: (2014)

Late Prevertebral and Spinal Abscess following Chemoradiation for Laryngeal Squamous Cell Carcinoma
por: Hindy, Jawad, et al.
Publicado: (2014)

Proton beam therapy with concurrent chemotherapy is feasible in children with newly diagnosed rhabdomyosarcoma
por: Suzuki, Ryoko, et al.
Publicado: (2021)

Online learning in proton radiation therapy: the future in the post-Covid-19 pandemic era?
por: Croxford, William, et al.
Publicado: (2021)

IMRT Reduces Acute Toxicity in Patients Treated With Preoperative Chemoradiation for Gastric Cancer
por: Moningi, Shalini, et al.
Publicado: (2019)

Enhanced toxicity to chemoradiation in a patient with Anti-Jo-1-antisynthetase syndrome
por: Valle, Luca, et al.
Publicado: (2022)

A Prospective Study of Early Radiation Associated Cardiac Toxicity Following Neoadjuvant Chemoradiation for Distal Esophageal Cancer
por: Burke, Aidan M., et al.
Publicado: (2020)

Machine Learning Approach to Forecast Chemotherapy-Induced Haematological Toxicities in Patients with Rhabdomyosarcoma
por: Cuplov, Vesna, et al.
Publicado: (2020)

Preliminary results of proton radiotherapy for pediatric rhabdomyosarcoma: a multi‐institutional study in Japan
por: Mizumoto, Masashi, et al.
Publicado: (2018)

Efficacy and safety of proton beam therapy for rhabdomyosarcoma: a systematic review and meta-analysis
por: Dong, Meng, et al.
Publicado: (2023)

Methylenetetrahydrofolate reductase genetic polymorphisms and toxicity to 5-FU-based chemoradiation in rectal cancer
por: Thomas, F, et al.
Publicado: (2011)

Caveolins in rhabdomyosarcoma
por: Rossi, Stefania, et al.
Publicado: (2011)

Relapsed Rhabdomyosarcoma
por: Heske, Christine M., et al.
Publicado: (2021)

Human Rhabdomyosarcoma Cell Lines for Rhabdomyosarcoma Research: Utility and Pitfalls
por: Hinson, Ashley R. P., et al.
Publicado: (2013)

Early Life Factors and Risk of Childhood Rhabdomyosarcoma
por: Shrestha, Anshu, et al.
Publicado: (2013)

Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma
por: Pomella, Silvia, et al.
Publicado: (2022)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Pure testicular rhabdomyosarcoma.
por: Alexander, F.
Publicado: (1968)

Primary Meningeal Rhabdomyosarcoma
por: Palta, Manisha, et al.
Publicado: (2011)

Pancreatic pleomorphic rhabdomyosarcoma
por: Shirafkan MD, Ali, et al.
Publicado: (2015)

Intracardiac Metastatic Rhabdomyosarcoma
por: Kim, Tae Ho, et al.
Publicado: (2015)

Congenital Rhabdomyosarcoma of Shoulder
por: Khaleghnejad-Tabari, Ahmad, et al.
Publicado: (2012)

Alveolar rhabdomyosarcoma of maxilla
por: Ananthaneni, Anuradha, et al.
Publicado: (2016)

Rhabdomyosarcoma of Urinary Bladder
por: Priyadarshi, Vinod, et al.
Publicado: (2014)

Rhabdomyosarcoma of the maxillary gingiva
por: Motallebnejad, Mina, et al.
Publicado: (2018)

FAK Signaling in Rhabdomyosarcoma
por: Perrone, Clara, et al.
Publicado: (2020)

Congenital Sacrococcygeal Rhabdomyosarcoma
por: Inuganti, Renuka Venkata, et al.
Publicado: (2022)

The role of bone marrow and spleen irradiation in the development of acute hematologic toxicity during chemoradiation for esophageal cancer
por: Chin, Alexander L., et al.
Publicado: (2018)

Primary Concurrent Chemoradiation in Head and Neck Cancers with Weekly Cisplatin Chemotherapy: Analysis of Compliance, Toxicity and Survival
por: Iqbal, Muhammad Shahid, et al.
Publicado: (2016)

Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: The impact of proton therapy and/or deep inspiration breath hold
por: Rechner, Laura Ann, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0rgdqsc6g3tso3677vlcqvm9dq